Neurocrine Biosciences NBIX
NASDAQ NBIX
$142.70 -0.59 (-0.41%)
At close: Oct 23, 2026 · 4:00 PM EDT

Neurocrine Biosciences (NBIX) Purchase of Investments (2010 - 2026)

Updated

Analysis

Neurocrine Biosciences (NBIX) Purchase of Investments (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Purchased (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 307.00 Mn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 919.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 834.00 Mn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 148.00 Mn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 46.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 42.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.54 Bn
10 Neurocrine Biosciences 14.50 Bn 10.20 Bn 935.80 Mn 37.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37.40 Mn
Mar 31, 2026 819.50 Mn
Dec 31, 2025 323.00 Mn
Sep 30, 2025 408.50 Mn
Jun 30, 2025 315.10 Mn
Mar 31, 2025 273.20 Mn
Dec 31, 2024 311.80 Mn
Sep 30, 2024 232.50 Mn
Jun 30, 2024 191.70 Mn
Mar 31, 2024 320.10 Mn
Dec 31, 2023 487.20 Mn
Sep 30, 2023 362.70 Mn
Jun 30, 2023 323.80 Mn
Mar 31, 2023 237.50 Mn
Dec 31, 2022 233.30 Mn
Sep 30, 2022 134.20 Mn
Jun 30, 2022 60.90 Mn
Mar 31, 2022 200.50 Mn
Dec 31, 2021 141.40 Mn
Sep 30, 2021 280.20 Mn
API Access

Neurocrine Biosciences Purchase of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=purchase-of-investments&ticker=NBIX&period=max&api_key=YOUR_API_KEY